Butane

Butane

SCHEMBL82391

CCCC.[N-]=[N+]=NP(=O)(N=[N+]=[N-])N=[N+]=[N-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL9619073 0.82
SCHEMBL5134080 0.77
SCHEMBL82393 0.72
SCHEMBL11580003 0.72
SCHEMBL247088 0.70 GABBR2 (0.39)
SCHEMBL2362730 0.69 LPAR3 (0.46)
SCHEMBL445948 0.69 LPAR3 (0.46)
SCHEMBL11582453 0.67 LPAR3 (0.50)
SCHEMBL3316407 0.67
Phosphoric Acid SCHEMBL15540528 0.64 FDPS (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160208114-A1 CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS HERAEUS MEDICAL COMPONENTS LLC 2016-07-21 US claimed
EP-3039087-A1 CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS SurModics, Inc. (US) 2016-07-06 EP claimed
WO-2015031265-A1 CONDUCTIVE POLYMERIC COATINGS, MEDICAL DEVICES, COATING SOLUTIONS AND METHODS SURMODICS, INC. (US) 2015-03-05 WO claimed
EP-1577670-B1 Latent reactive polymers with biologically active moieties, method of preparing a biocompatible coating and bulk material, and use SURMODICS INC (US) 2015-01-28 EP claimed
EP-1577670-A2 Latent reactive polymers with biologically active moieties SurModics, Inc. (US) 2005-09-21 EP claimed
US-6514734-B1 Pendent bioactive groups function by promoting attachment of specific molecules or cells to the bulk material or coated surface; bioactive groups can include proteins, peptides, carbohydrates, and nucleic acids; e.g. neurons to electrodes SURMODICS, INC. 2003-02-04 US claimed
US-20030013696-A1 Methods and compositions for photo-cross linking photoactive compounds to target tissue BRITISH COLUMBIA, UNIVERSITY OF, THE (CA) 2003-01-16 US claimed
WO-2002076453-A1 METHODS AND COMPOSITIONS FOR PHOTO-CROSS LINKING PHOTOACTIVE COMPOUNDS TO TARGET TISSUE THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2002-10-03 WO claimed
US-12616777-B2 Silicone polyurea block copolymer coating compositions and methods INNOVATIVE SURFACE TECHNOLOGIES, INC. (US) 2026-05-05 US disclosed
US-20260108663-A1 LOW PARTICULATE LUBRICIOUS COATING WITH VINYL PYRROLIDONE AND ACIDIC POLYMER-CONTAINING LAYERS SURMODICS INC (US) 2026-04-23 US disclosed
US-12582752-B2 Medical device and method for manufacturing same TERUMO KABUSHIKI KAISHA (JP) 2026-03-24 US disclosed
EP-3723820-B1 SILICONE POLYUREA BLOCK COPOLYMER COATING COMPOSITIONS AND METHODS INNOVATIVE SURFACE TECH INC (US) 2026-02-11 EP disclosed
US-20250313522-A1 PHENOXY CARBOXYLIC ACID COMPOUNDS AND MEDICAL USES THEREOF QINGDAO RISING BIOTECHNOLOGY CO., LTD (CN) 2025-10-09 US disclosed
US-12409253-B2 Low particulate lubricious coating with vinyl pyrrolidone and acidic polymer-containing layers SURMODICS, INC. (US) 2025-09-09 US disclosed
CN-1054975-A Produce the method for new 5-fluorine nicotinic acid or derivatives thereof or its carboxyl response activity derivant and their salt TOYAMA CHEMICAL CO LTD (JP) 1991-10-02 CN disclosed
EP-0425485-A1 PREPARATION OF POLYMERIC SURFACES BSI Corporation (US) 1991-05-08 EP disclosed
US-5002582-A Natural or synthetic resins bonded through latent reactive groups BIO-METRIC SYSTEMS, INC. (US) 1991-03-26 US disclosed
WO-1990000887-A1 PREPARATION OF POLYMERIC SURFACES BIO-METRIC SYSTEMS, INC. (US) 1990-02-08 WO disclosed
EP-0325778-A2 Method for obtaining a uniform blend of polymers GENERAL ELECTRIC COMPANY (US) 1989-08-02 EP disclosed
CN-86100879-A Novel process for preparing 1-substituted aryl-1, 4-dihydro-4-oxo-1, 8-naphthyridine derivatives and intermediates thereof 1986-12-17 CN disclosed